Eli Lilly has unveiled plans to invest at least $27bn in building four new pharmaceutical manufacturing sites in the US.

Avtozma, which is Celltrion’s twelfth biosimilar to be approved by the EC, is a recombinant humanised monoclonal antibody ...

Tired of the disconnect in virtual meetings? Discover how using webcams can enhance communication, build stronger relationships, and create a more engaging work environment.

The challenge for companies is to ensure their local affiliates meet local PV obligations while staying aligned with global PV requirements ...

Johnson & Johnson (J&J) has shared positive results from a late-stage study evaluating a subcutaneous (SC) version of Tremfya ...

NHS England has announced that it has appointed Sir James Mackey as its new chief executive officer (CEO), following Amanda ...

The phase 3 SERENA-6 study randomised patients with HR-positive, HER2-negative advanced breast cancer whose tumours had an ...

Amgen’s Blincyto (blinatumomab) has been recommended by the National Institute for Health and Care Excellence (NICE) to treat ...

Global healthcare communications company Porterhouse Medical has announced the appointment of Michael Tague as president of ...

The US Food and Drug Administration (FDA) has approved Mirum Pharmaceuticals’ Ctexli (chenodiol) to treat adults with ...

At Precision Medicine Group (PMG), DEI is a key consideration across the drug development process, especially when it comes to patient engagement in clinical trials. We start with insights and a firm ...

Recce Pharmaceuticals has shared positive data from a mid-stage study of its RECCE 327 topical gel (R327G) in acute bacterial ...